Picton Mahoney Asset Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$660 Hold
38
﹤0.01% 1218
2025
Q4
$716 Hold
38
﹤0.01% 1173
2025
Q3
$1K Hold
38
﹤0.01% 889
2025
Q2
$1K Hold
38
﹤0.01% 766
2025
Q1
$1K Hold
38
﹤0.01% 738
2024
Q4
$1K Hold
38
﹤0.01% 633
2024
Q3
$1K Buy
+38
New +$946 ﹤0.01% 624
2019
Q3
Sell
-86,500
Closed -$3.11M 198
2019
Q2
$3.11M Sell
86,500
-4,000
-4% -$128K 0.21% 94
2019
Q1
$2.85M Sell
90,500
-2,300
-2% -$67K 0.22% 94
2018
Q4
$2.33M Buy
+92,800
New +$2.38M 0.21% 86

Other funds holding CDNA

Picton Mahoney Asset Management's CDNA Position: Q1 2026 in Review

Picton Mahoney Asset Management held its CareDx (CDNA) position steady in Q1 2026 at 38 shares worth $660. The position accounts for ﹤0.01% of the portfolio, ranked #1218.

Picton Mahoney Asset Management first reported a position in CDNA in Q4 2018 and has held it in 10 quarters since. The position peaked at $3.11M in Q2 2019. 190 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.

  • Picton Mahoney Asset Management held 38 shares of CareDx worth $660 as of Q1 2026.
  • Picton Mahoney Asset Management left its CareDx share count unchanged in Q1 2026.
  • CareDx made up ﹤0.01% of Picton Mahoney Asset Management's portfolio in Q1 2026, its #1218 holding.
  • Picton Mahoney Asset Management first reported a position in CareDx in Q4 2018 and has held it in 10 quarters since.
  • Picton Mahoney Asset Management's CareDx position peaked at $3.11M in Q2 2019.
  • 190 funds tracked by Wall St. Rank held CareDx as of Q1 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2026, filed 13 May 2026.